EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Biochemical Evaluation of Bone Health in Children with Phenylketonuria, Organic Acidemias, and Glycogen Storage Diseases Under Dietary Management

Sabire Gokalp iD, Hatice Pasaoglu

Nutrients · 2026

DOI: 10.3390/nu18172751 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nutrients, 2026. Verfasst von Sabire Gokalp und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Metabolic Disorders, Etlik City Hospital, Ankara 06170, Turkey. Hauptthemen laut MEDLINE: Phenylketonurias, Bone and Bones, Glycogen Storage Disease. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Gazi University, Gazi University Scientific Research Projects Coordination Unit.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Inherited metabolic disorders (IMDs) are a heterogeneous group of genetic diseases, some of which require lifelong disease-specific dietary management. Children with phenylketonuria (PKU), organic acidemias (OAs), and glycogen storage diseases (GSDs) are particularly susceptible to nutritional imbalances and metabolic disturbances that may adversely affect bone metabolism and skeletal health. However, data regarding bone turnover markers and bone health in these pediatric IMD populations remain limited.

Objective

This study aimed to evaluate bone metabolism by assessing biochemical parameters, bone turnover markers, and bone mineral density in children with PKU, OA, and GSD receiving long-term dietary treatment.

Methods

This cross-sectional study included 95 children, comprising 25 patients with PKU, 20 patients with organic acidemias, 20 patients with glycogen storage diseases, and 30 healthy age-matched controls. Demographic characteristics, anthropometric measurements, and dietary intake were recorded. Biochemical evaluation included serum calcium, phosphorus, alkaline phosphatase (ALP), parathyroid hormone (PTH), and 25-hydroxyvitamin D levels. Bone turnover was assessed using C-terminal telopeptide of type I collagen (CTX), procollagen type I N-terminal propeptide (P1NP), and osteocalcin (OC) levels. Bone mineral density was evaluated by dual-energy X-ray absorptiometry (DXA).

Results

Age and sex distributions were similar among the groups. Height was lower in OA than in controls and PKU, and in GSD than in PKU; weight and BMI were lower in both OA and GSD than in controls and PKU (p < 0.05). Significant differences were observed in dietary energy and macronutrient intake according to disease-specific nutritional regimens. Serum calcium, phosphorus, and 25-hydroxyvitamin D levels were significantly lower in all IMD groups compared with healthy controls (p < 0.001). ALP and PTH levels were significantly higher in PKU, OA, and GSD patients than in controls (p < 0.001). Among bone turnover markers, P1NP and osteocalcin levels significantly differed among groups, with the highest values observed in PKU patients (p = 0.006 and p = 0.028, respectively). CTX levels did not significantly differ among the groups (p = 0.183). DXA Z-scores were significantly lower in all IMD groups than in controls, with the lowest mean Z-scores observed in GSD patients.

Conclusions

Children with PKU, OA, and GSD receiving long-term dietary treatment exhibited significant alterations in bone metabolism, characterized by lower vitamin D, calcium, and phosphorus levels, higher ALP and PTH concentrations, differences in bone formation markers, and lower DXA Z-scores compared with controls. Significant differences were observed in the bone formation markers P1NP and osteocalcin, whereas CTX levels remained comparable among the study groups. These findings underscore the importance of regular assessment of bone health and optimization of nutritional management in children under dietary treatment, while acknowledging that disease-specific mechanisms of skeletal involvement may differ among these conditions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PhenylketonuriasBone and BonesGlycogen Storage DiseaseHumansMaleFemaleChildCross-Sectional StudiesBone DensityBiomarkersVitamin DChild, PreschoolAdolescentCalciumOsteocalcinBone RemodelingAlkaline PhosphataseParathyroid HormoneCollagen Type I

Stichwörter der Autor:innen

bone healthbone turnover markersdietary managementglycogen storage diseasesinherited metabolic disordersorganic acidemiasphenylketonuria

Substanzen

BiomarkersVitamin DCalciumOsteocalcin25-hydroxyvitamin DAlkaline PhosphataseParathyroid HormoneCollagen Type I

Autor:innen und Institutionen

  • Department of Pediatric Metabolic Disorders, Etlik City Hospital, Ankara 06170, Turkey.
  • Department of Medical Biochemistry, Faculty of Medicine, Gazi University, Ankara 06560, Turkey.

ORCID-Profile: Sabire Gokalp

Förderung

  • Gazi University
  • Gazi University Scientific Research Projects Coordination Unit

Zitieren

APA

Gokalp, S., & Pasaoglu, H. (2026). Biochemical Evaluation of Bone Health in Children with Phenylketonuria, Organic Acidemias, and Glycogen Storage Diseases Under Dietary Management. Nutrients. https://doi.org/10.3390/nu18172751

Vancouver

Gokalp S, Pasaoglu H. Biochemical Evaluation of Bone Health in Children with Phenylketonuria, Organic Acidemias, and Glycogen Storage Diseases Under Dietary Management. Nutrients. 2026. doi:10.3390/nu18172751

BibTeX
@article{Gokalp2026,
  author = {Gokalp, Sabire and Pasaoglu, Hatice},
  title = {Biochemical Evaluation of Bone Health in Children with Phenylketonuria, Organic Acidemias, and Glycogen Storage Diseases Under Dietary Management},
  journal = {Nutrients},
  year = {2026},
  doi = {10.3390/nu18172751}
}
Kostenlos starten →